Skip to main content
HCAT
NASDAQ Technology

Activist Investor Whetstone Capital Advisors Increases Stake to 8.2% in Health Catalyst

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Positive
Importance info
9
Price
$1.69
Mkt Cap
$119.535M
52W Low
$1.67
52W High
$5.56
Market data snapshot near publication time

summarizeSummary

Whetstone Capital Advisors, an activist investor, has increased its beneficial ownership in Health Catalyst, Inc. to 8.2%, continuing to build its position after proposing significant corporate changes.


check_boxKey Events

  • Increased Ownership

    Whetstone Capital Advisors now beneficially owns 8.2% of Health Catalyst's common stock, up from 7.4% previously reported in their January 21, 2026 filing.

  • Continued Accumulation

    The activist investor purchased over 500,000 additional shares in the open market during February, totaling approximately $1.01 million, demonstrating ongoing commitment.

  • Activist Conviction

    The purchases were made while the stock was trading near its 52-week lows, reinforcing Whetstone's commitment to its investment thesis and its ability to influence corporate strategy, especially following recent leadership changes.


auto_awesomeAnalysis

This Schedule 13D/A indicates that Whetstone Capital Advisors has increased its beneficial ownership in Health Catalyst, Inc. from 7.4% to 8.2%. The filing details over $1 million in additional share purchases made in the open market during February, with transactions occurring at prices ranging from $1.76 to $2.31. This continued accumulation by an activist investor, especially while the stock is trading near its 52-week lows, signals strong conviction in the company's potential or in the activist's ability to drive change. This follows Whetstone's initial Schedule 13D filing on January 21, where they proposed significant corporate changes, and precedes the recent leadership overhaul announced on February 18. The increased stake strengthens Whetstone's position to influence strategic decisions.

At the time of this filing, HCAT was trading at $1.69 on NASDAQ in the Technology sector, with a market capitalization of approximately $119.5M. The 52-week trading range was $1.67 to $5.56. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HCAT - Latest Insights

HCAT
Apr 27, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
HCAT
Apr 02, 2026, 5:56 PM EDT
Filing Type: 8-K
Importance Score:
7
HCAT
Mar 12, 2026, 4:58 PM EDT
Filing Type: 10-K
Importance Score:
9
HCAT
Mar 12, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
9
HCAT
Mar 12, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
HCAT
Feb 18, 2026, 1:04 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
HCAT
Feb 18, 2026, 8:59 AM EST
Filing Type: 8-K
Importance Score:
9
HCAT
Jan 23, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
HCAT
Jan 21, 2026, 8:39 AM EST
Filing Type: SCHEDULE 13D
Importance Score:
8
HCAT
Jan 12, 2026, 4:26 PM EST
Filing Type: 8-K
Importance Score:
7